Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- LY3023414 and Prexasertib in Metastatic Triple-negative Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of LY3023414 and Prexasertib in Metastatic Triple-negative Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04032080).
- LY3819253 (LY-CoV555) for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial): Complete Statistical AnalysisIndependent statistical analysis of LY3819253 (LY-CoV555) for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05780268).
- Lymphoma RadVax LYMPHOMA: A PHASE II TRIAL OF NIVOLUMAB + LOW DOSE RADIOTHERAPY FOR INCOMPLETE RESPONDERS: Complete Statistical AnalysisIndependent statistical analysis of Lymphoma RadVax LYMPHOMA: A PHASE II TRIAL OF NIVOLUMAB + LOW DOSE RADIOTHERAPY FOR INCOMPLETE RESPONDERS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- LYNXIndependent statistical analysis of A Comparison of Body Fat Distribution in HIV-1 Infected Patients Receiving, Since the Beginning and for at Least Two Years, an Antiretroviral Therapy Based on Efavirenz or Lopinavir/Ritonavir…
- Lyophilized Black Raspberries in Adults With Familial Adenomatous Polyposis (FAP): Complete Statistical AnalysisIndependent statistical analysis of Lyophilized Black Raspberries in Adults With Familial Adenomatous Polyposis (FAP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00770991).
- Lyophilized IMVAMUNE® (1×10^8 TCID50) Versus Liquid IMVAMUNE® (1×10^8 TCID50) Administered Subcutaneously and a Lower Dose Liquid IMVAMUNE® (2×10^7 TCID50) Administered Intradermally: Complete Statistical AnalysisIndependent statistical analysis of Lyophilized IMVAMUNE® (1x10^8 TCID50) Versus Liquid IMVAMUNE® (1x10^8 TCID50) Administered Subcutaneously and a Lower Dose Liquid IMVAMUNE® (2x10^7 TCID50) Administered Intradermally: primary endpoint results, effect estimate with confidence…
- Lyrica (Pregabalin) Korean Post Marketing Surveillance Study: Complete Statistical AnalysisIndependent statistical analysis of Lyrica (Pregabalin) Korean Post Marketing Surveillance Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01220180).
- LYT-100 in Post-acute COVID-19 Respiratory Disease: Complete Statistical AnalysisIndependent statistical analysis of LYT-100 in Post-acute COVID-19 Respiratory Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04652518).
- M-DEPTHIndependent statistical analysis of Maternal Depression Treatment in HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03892915).
- M-F0434Independent statistical analysis of Neuropathic Pain Management: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01263132).
- M-MILKIndependent statistical analysis of Multisensory Early Oral Administration of Human Milk in Preterm Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06230848).
- M-PLACEIndependent statistical analysis of Trial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- M-RePoRTIndependent statistical analysis of Metformin for Rising PSA Remote Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02376166).
- M-UnityIndependent statistical analysis of Beta-glucan and Immune Response to Influenza Vaccine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05074303).
- M&MIndependent statistical analysis of Metformin and Muscle in Insulin-resistant Older Veterans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01804049).
- M032-HSV-1Independent statistical analysis of Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant Glioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- M2-ABMGIndependent statistical analysis of A Study to Evaluate the Safety and Immunogenicity of Oral Polio Vaccine Type 2 in Infants and Children: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- M3541 in Combination With Radiotherapy in Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of M3541 in Combination With Radiotherapy in Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03225105).
- M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers: Complete Statistical AnalysisIndependent statistical analysis of M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- M7824 in People With Recurrent Respiratory Papillomatosis: Complete Statistical AnalysisIndependent statistical analysis of M7824 in People With Recurrent Respiratory Papillomatosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03707587).
- M7824 Versus Pembrolizumab as a First-line (1L) Treatment in Participants With Programmed Death-ligand 1 (PD-L1) Expressing Advanced Non-small Cell Lung Cancer (NSCLC): Complete Statistical AnalysisIndependent statistical analysis of M7824 Versus Pembrolizumab as a First-line (1L) Treatment in Participants With Programmed Death-ligand 1 (PD-L1) Expressing Advanced Non-small Cell Lung Cancer (NSCLC): primary endpoint results, effect estimate with…
- M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC): Complete Statistical AnalysisIndependent statistical analysis of M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- MA-51Independent statistical analysis of Evaluation of Capsule Endoscopy in Patients With Suspected Crohn's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00487396).
- MA181Independent statistical analysis of Assessing Choice in the Employer Setting (ACES) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00808808).
- MACH19Independent statistical analysis of RCT of Mushroom Based Natural Product to Enhance Immune Response to COVID-19 Vaccination: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Macrophage Phagocytosis in COPD: Complete Statistical AnalysisIndependent statistical analysis of Macrophage Phagocytosis in COPD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00298389).
- MACRTIndependent statistical analysis of Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MACS-RCTIndependent statistical analysis of Mobile After-Care Support App: Pilot RCT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03955250).
- MACS0911Independent statistical analysis of Study to Evaluate Nilotinib in Chronic Myelogenous Leukemia (CML) Patients With SubOptimal Response: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MACS1148Independent statistical analysis of Study of Nilotinib in Ph+ CML-CP Patients With Low Imatinib Trough Plasma Concentrations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MACULAIndependent statistical analysis of Efficacy And Safety Of Macugen In Patients With Neovascular AMD In Routine Clinical Practice.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- MADIndependent statistical analysis of Magnetic Anastomosis Device Relief of Malignant Gastric Outlet Obstruction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00487552).
- MADIndependent statistical analysis of Mandibular Advancement Device and Changes in Nocturia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05562388).
- MaestroIndependent statistical analysis of A Pilot Study of Mirabegron and Behavioral Modification Including Pelvic Floor Exercise for Overactive Bladder in Parkinson's Disease (MAESTRO): primary endpoint results, effect estimate with confidence interval, sample-size…
- MAESTROIndependent statistical analysis of IMAging With Opto-acoustics to downgradE BI-RADS claSsificaTion Relative tO Other Diagnostic Methodologies (MAESTRO): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MAESTROIndependent statistical analysis of Nexium (Esomeprazole) in Symptom Adapted Therapy in GERD Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00444275).
- MAGE-A3 Protein + AS15 as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation: Complete Statistical AnalysisIndependent statistical analysis of MAGE-A3 Protein + AS15 as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MAGE-A4ᶜ¹º³²T for Multi-Tumor: Complete Statistical AnalysisIndependent statistical analysis of MAGE-A4ᶜ¹º³²T for Multi-Tumor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03132922).
- MAGELLANIndependent statistical analysis of Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MAGELLAN-3Independent statistical analysis of Efficacy and Safety of Glecaprevir (ABT-493)/Pibrentasvir (ABT 530) (GLE/PIB) in Combination With Sofosbuvir and Ribavirin in Participants With Hepatitis C Virus Who Did Not Respond to Treatment in…
- MAGiC-ARTIndependent statistical analysis of Interleukin-1 Blockade for Treatment of Cardiac Sarcoidosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04017936).
- Magnesium L-Threonate for the Enhancement of Learning and Memory in People With Dementia: Complete Statistical AnalysisIndependent statistical analysis of Magnesium L-Threonate for the Enhancement of Learning and Memory in People With Dementia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Magnesium Sulfate vs Placebo for Placental Abruption: Complete Statistical AnalysisIndependent statistical analysis of Magnesium Sulfate vs Placebo for Placental Abruption: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00186069).
- Magnesium Supplementation for the Prevention of Supraventricular Arrhythmias: Complete Statistical AnalysisIndependent statistical analysis of Magnesium Supplementation for the Prevention of Supraventricular Arrhythmias: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02837328).
- Magnesium Supplements In The Treatment Of Pseudoxanthoma Elasticum (PXE): Complete Statistical AnalysisIndependent statistical analysis of Magnesium Supplements In The Treatment Of Pseudoxanthoma Elasticum (PXE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01525875).
- Magnesium vs Placebo for Tonsillectomy: Complete Statistical AnalysisIndependent statistical analysis of Magnesium vs Placebo for Tonsillectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02218424).
- MAGNET (Magnetically Controlled Capsule for Assessment of Gastric Mucosa in Symptomatic Patients): Complete Statistical AnalysisIndependent statistical analysis of MAGNET (Magnetically Controlled Capsule for Assessment of Gastric Mucosa in Symptomatic Patients): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Magnetic Resonance Elastography for Assessment of Liver Fibrosis (MK-0000-132)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of Magnetic Resonance Elastography for Assessment of Liver Fibrosis (MK-0000-132)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00896233).
- Magnetic Resonance Imaging (MRI) Brachytherapy Applicator Study: Complete Statistical AnalysisIndependent statistical analysis of Magnetic Resonance Imaging (MRI) Brachytherapy Applicator Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01706705).
- Magnetic Resonance Imaging (MRI) of Appendicitis in Children: Complete Statistical AnalysisIndependent statistical analysis of Magnetic Resonance Imaging (MRI) of Appendicitis in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00723788).